FDA delays decision on Moderna’s COVID-19 vaccine in 12-17 age group because of myocarditis concerns
After reports in four Nordic countries of the heart inflammation condition myocarditis, the FDA has delayed a decision on the Moderna COVID-19 shot for kids between t...
Continue Reading →
